STOCK TITAN

Zai Lab Announces Participation in March Investor Conferences

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) announced that its senior management will participate in two upcoming investor conferences in March 2023. The conferences are the Jefferies 2023 Biotech on the Bay Summit on March 16 in Miami and the 26th Credit Suisse Asian Investment Conference from March 20 to 23 in Hong Kong. Zai Lab is a biopharmaceutical company focusing on innovative medicines for various diseases, including oncology and autoimmune disorders. For more information, visit their website.

Positive
  • Participation in notable investor conferences can enhance visibility and attract investor interest.
  • Focus on transformative medicines positions Zai Lab favorably in the biopharmaceutical sector.
Negative
  • None.

SHANGHAI and CAMBRIDGE, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), today announced that members of the company’s senior management team will participate in the following investor conferences in March 2023:

Jefferies 2023 Biotech on the Bay Summit
Panel Discussion: Thursday, March 16, 2023, 12:15 p.m. ET
Location: Miami

26th Credit Suisse Asian Investment Conference
Date: Monday, March 20 to Thursday, March 23, 2023
Location: Hong Kong

About Zai Lab

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States focused on bringing transformative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders to patients in China and around the world. Our goal is to leverage our competencies and resources to positively impact human health worldwide.

For additional information about Zai Lab, including our products, business activities and partnerships, research, and other events or developments, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

Investor Relations: Lina Zhang
+86 136 8257 6943
lina.zhang@zailaboratory.com

Media: Christine Drury / Xiaoyu Chen
+1 (317) 385-9227 / +86 185 0015 5011
christine.drury@zailaboratory.com / xiaoyu.chen@zailaboratory.com


FAQ

What investor conferences will Zai Lab participate in March 2023?

Zai Lab will participate in the Jefferies 2023 Biotech on the Bay Summit on March 16 and the Credit Suisse Asian Investment Conference from March 20 to 23.

What is Zai Lab's focus in the biopharmaceutical sector?

Zai Lab focuses on developing innovative medicines for oncology, autoimmune disorders, infectious diseases, and neurological disorders.

When is the Jefferies 2023 Biotech on the Bay Summit?

The Jefferies 2023 Biotech on the Bay Summit is scheduled for March 16, 2023.

Where will the 26th Credit Suisse Asian Investment Conference be held?

The 26th Credit Suisse Asian Investment Conference will take place in Hong Kong from March 20 to 23, 2023.

Zai Lab Limited American Depositary Shares

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Stock Data

2.84B
105.82M
1.97%
44.44%
4.96%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
SHANGHAI